Table of Contents
From the Editor
- Ebola—lessons still to be learned
So far, the disease has barely touched our country, but it has had a big impact on our health care system and our national psyche.
The Clinical Picture
- Sarcoidal infiltration of tattoos
Corticosteroid treatment resulted in clinical improvement after 3 months.
Smart Testing
- When does an adult with headaches need central nervous system imaging?
Without red-flag symptoms, central nervous system imaging is unwarranted and may be harmful.
1-Minute Consult
- Is antibiotic treatment indicated in a patient with a positive urine culture but no symptoms?
Some groups should be screened and treated, eg, pregnant women and patients undergoing an invasive urologic procedure.
Im Board Review
- A 41-year-old man with abdominal pain
His symptoms and imaging findings suggested an infarction in the spleen, but what caused the infarction?
Medical Grand Rounds
Ebola virus: Questions, answers, and more questionsThe clinical virology of Ebola virus, the reported proposed treatments, and an overview of the current outbreak.
Review
- Identifying statin-associated autoimmune necrotizing myopathy
Unlike simple myalgia or myositis, this condition can persist or even arise de novo after the statin is stopped.
- Updated guidelines on cardiovascular evaluation before noncardiac surgery: A view from the trenches
The purpose is not to get clearance for surgery but to evaluate the patient’s medical status and risk of complications.
- Syncope: Etiology and diagnostic approach
There are three major types: neurally mediated, orthostatic, and cardiac. The goal is to rule out structural heart disease.
Editorial
- Perioperative medicine: Combining the science and the art
Although we may wish for “cookbook” guidelines, often we must practice the “art” of medicine.
Patient Education
Departments
- Diabetes therapy and cancer risk (October 2014)
A reader comments on the risk of cancer with diabetes drugs (October 2014).
- In Reply: Diabetes therapy and cancer risk (October 2014)
A reader comments on the risk of cancer with diabetes drugs (October 2014).
